This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.
Original paper

Environmental risk assessment of metformin and its transformation product guanylurea. I. Environmental fate

Volume: 216, Pages: 844 - 854
Published: Oct 9, 2018
Abstract
Metformin (MET) is a pharmaceutical with very high use worldwide that is excreted in unchanged form, leading to concern about potential aquatic life impacts associated with MET, and its primary transformation product guanylurea (GUU). This study presents, in two companion papers, a risk assessment following internationally accepted guidelines of MET and GUU in surface water based on literature data, previously unpublished studies, and a new...
Paper Details
Title
Environmental risk assessment of metformin and its transformation product guanylurea. I. Environmental fate
Published Date
Oct 9, 2018
Volume
216
Pages
844 - 854
© 2025 Pluto Labs All rights reserved.
Step 1. Scroll down for details & analytics related to the paper.
Discover a range of citation analytics, paper references, a list of cited papers, and more.